Amy L Pasternak

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 13

Top Venues

Clinical and translational science

Pharmacogenomics

Journal of personalized medicine

JCO oncology practice

University of Michigan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan Jan 01 2018

United States

Clinical Assistant Professor :: Clinical Pharmacy

Publications

Kyoin Koo, Amy L Pasternak, Norah L Henry, Vaibhav Sahai, Daniel Louis Hertz
Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy. JCO oncology practice 18 (6) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Amy L Pasternak, Kristen Ward, Madison N Irwin, Carl Okerberg, David Hayes, Lars G Fritsche, Sebastian Zoellner, Jessica Virzi, Hae Mi Choe, Vicki Ellingrod
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clinical and translational science 16 (2) (2022)
Lauren Schumacher, Fang Fang, Kelley M Kidwell, Faisal Shakeel, Daniel Louis Hertz, Jeong Mi Park, Amy L Pasternak
SLCO1B3 polymorphisms and clinical outcomes in kidney transplant recipients receiving mycophenolate. Pharmacogenomics 22 (17) (2021)
Abbie D Leino, Jeong Mi Park, Amy L Pasternak
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients. Pharmacotherapy 41 (8) (2021)
Sony Tuteja, Ramzi George Salloum, Amanda L Elchynski, D Max Smith, Elizabeth J Rowe, Kathryn V Blake, Nita A Limdi, Christina L Aquilante, Jill Bates, Amber L Beitelshees, Amber B Cipriani, Benjamin Q Duong, Philip E Empey, Christine M Formea, J Kevin Hicks, Pawel Mroz, David Oslin, Amy L Pasternak, Natasha J Petry, Laura B Ramsey, Allyson Schlichte, Sandra M Swain, Kristen M Ward, Kristin Wiisanen, Todd C Skaar, Sara L Van Driest, Larisa H Cavallari, Jeffrey R Bishop, null null
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. Clinical and translational science (2021)
Amy L Pasternak, Vincent D Marshall, Christina L Gersch, James M Rae, Michael Englesbe, Jeong Mi Park
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus. Pharmacogenomics and personalized medicine 14 (2021)
Faisal Shakeel, Fang Fang, Jung Won Kwon, Kyoin Koo, Amy L Pasternak, Norah L Henry, Vaibhav Sahai, Kelley M Kidwell, Daniel Louis Hertz
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapy. Pharmacogenomics 22 (3) (2021)
Jing 'Daisy' Zhu, Amy L Pasternak, Daniel J Crona
The future of research into genetics and the precision dosing of tacrolimus: what do we need to know? Pharmacogenomics 21 (15) (2020)
Amy L Pasternak, Kristen M Ward, Mohammed B Ateya, Hae Mi Choe, Amy N Thompson, John S Clark, Vicki L Ellingrod
Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center. Journal of personalized medicine 10 (4) (2020)

Amy L Pasternak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amy L Pasternak